Sanofi and GSK’s next-generation COVID-19 booster vaccine VidPrevtyn Beta approved by the European Commission

Sanofi

10 November 2022 - First and only next-generation protein-based adjuvanted COVID-19 booster approved in Europe.

After the EMA’s CHMP adopted a positive opinion for VidPrevtyn Beta, the vaccine was approved by the European Commission, as a booster for the prevention of COVID-19 in adults 18 years of age and older.

Read Sanofi press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Outcome , Europe , Vaccine , COVID-19